$CLFD
Clearfield, Inc.

2021 Q3 Form 10-K Financial Statement

#000117184321007797 Filed on November 10, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2021 2020 Q3
Revenue $45.24M $140.8M $27.32M
YoY Change 65.58% 51.23% 13.98%
Cost Of Revenue $25.51M $79.58M $16.07M
YoY Change 58.72% 44.27% 9.62%
Gross Profit $19.73M $61.18M $11.25M
YoY Change 75.37% 61.36% 20.97%
Gross Profit Margin 43.61% 43.46% 41.18%
Selling, General & Admin $10.36M $35.94M $7.570M
YoY Change 36.89% 21.72% 6.17%
% of Gross Profit 52.52% 58.75% 67.29%
Research & Development $1.243M
YoY Change -2.05%
% of Gross Profit 2.03%
Depreciation & Amortization $576.3K $2.302M $600.0K
YoY Change -3.95% -4.95% 5.26%
% of Gross Profit 2.92% 3.76% 5.33%
Operating Expenses $10.36M $37.19M $7.570M
YoY Change 36.89% 20.74% 6.17%
Operating Profit $9.367M $25.23M $3.680M
YoY Change 154.54% 200.98% 69.59%
Interest Expense $121.9K $500.1K $160.0K
YoY Change -23.84% -35.05% -27.27%
% of Operating Profit 1.3% 1.98% 4.35%
Other Income/Expense, Net
YoY Change
Pretax Income $9.489M $25.73M $3.840M
YoY Change 147.11% 181.1% 60.0%
Income Tax $2.063M $5.407M $790.0K
% Of Pretax Income 21.74% 21.01% 20.57%
Net Earnings $7.426M $20.33M $3.050M
YoY Change 143.48% 178.72% 61.38%
Net Earnings / Revenue 16.42% 14.44% 11.16%
Basic Earnings Per Share $1.48
Diluted Earnings Per Share $536.2K $1.47 $217.2K
COMMON SHARES
Basic Shares Outstanding 13.74M 13.72M 13.65M
Diluted Shares Outstanding 13.78M

Balance Sheet

Concept 2021 Q3 2021 2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.59M $23.59M $27.00M
YoY Change -12.63% -12.73% 14.41%
Cash & Equivalents $13.22M $13.22M $16.45M
Short-Term Investments $10.37M $10.37M $10.60M
Other Short-Term Assets $954.0K $954.0K $585.4K
YoY Change 62.96% 61.69% -23.89%
Inventory $27.52M $27.52M $14.41M
Prepaid Expenses
Receivables $19.44M $19.44M $10.50M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $71.51M $71.51M $52.52M
YoY Change 36.14% 36.15% 23.56%
LONG-TERM ASSETS
Property, Plant & Equipment $4.998M $7.303M $4.953M
YoY Change 0.91% -4.54% -8.51%
Goodwill $4.709M $4.709M
YoY Change 0.01% 0.0%
Intangibles $4.696M $4.986M
YoY Change -5.82% -3.13%
Long-Term Investments $36.91M $36.91M $25.10M
YoY Change 47.06% 46.83% 5.02%
Other Assets $420.0K $784.4K $266.9K
YoY Change 57.39% 78.28% 26.53%
Total Long-Term Assets $54.41M $54.40M $42.77M
YoY Change 27.19% 27.17% 8.62%
TOTAL ASSETS
Total Short-Term Assets $71.51M $71.51M $52.52M
Total Long-Term Assets $54.41M $54.40M $42.77M
Total Assets $125.9M $125.9M $95.30M
YoY Change 32.13% 32.12% 16.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $9.215M $9.215M $3.690M
YoY Change 149.76% 149.72% 16.26%
Accrued Expenses $1.613M $11.26M $1.203M
YoY Change 34.11% 67.26% 476.58%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.47M $20.47M $10.41M
YoY Change 96.57% 96.65% 57.63%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.615M $1.615M $2.100M
YoY Change -23.08% -24.16% 950.0%
Total Long-Term Liabilities $1.615M $1.615M $2.129M
YoY Change -24.14% -24.16% 511.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.47M $20.47M $10.41M
Total Long-Term Liabilities $1.615M $1.615M $2.129M
Total Liabilities $22.09M $22.09M $12.54M
YoY Change 76.07% 76.13% 80.36%
SHAREHOLDERS EQUITY
Retained Earnings $45.44M $25.11M
YoY Change 80.94% 40.92%
Common Stock $137.0K $136.5K
YoY Change 0.37% 0.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $103.8M $103.8M $82.75M
YoY Change
Total Liabilities & Shareholders Equity $125.9M $125.9M $95.30M
YoY Change 32.13% 32.12% 16.37%

Cashflow Statement

Concept 2021 Q3 2021 2020 Q3
OPERATING ACTIVITIES
Net Income $7.426M $20.33M $3.050M
YoY Change 143.48% 178.72% 61.38%
Depreciation, Depletion And Amortization $576.3K $2.302M $600.0K
YoY Change -3.95% -4.95% 5.26%
Cash From Operating Activities $2.786M $10.90M $4.220M
YoY Change -33.99% 63.81% -27.49%
INVESTING ACTIVITIES
Capital Expenditures -$770.9K -$2.046M -$320.0K
YoY Change 140.9% -213.28% -77.3%
Acquisitions $0.00
YoY Change
Other Investing Activities -$9.694M -$11.55M $3.440M
YoY Change -381.81% -752.75% -1533.33%
Cash From Investing Activities -$10.46M -$13.60M $3.130M
YoY Change -434.34% 32966.91% -289.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net -$383.7K
YoY Change -580.35%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -409.8K -$536.4K -180.0K
YoY Change 127.67% 117.42% 50.0%
NET CHANGE
Cash From Operating Activities 2.786M $10.90M 4.220M
Cash From Investing Activities -10.46M -$13.60M 3.130M
Cash From Financing Activities -409.8K -$536.4K -180.0K
Net Change In Cash -8.089M -$3.233M 7.170M
YoY Change -212.82% -150.78% 77.04%
FREE CASH FLOW
Cash From Operating Activities $2.786M $10.90M $4.220M
Capital Expenditures -$770.9K -$2.046M -$320.0K
Free Cash Flow $3.557M $12.95M $4.540M
YoY Change -21.66% 167.01% -37.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-26879 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13216281 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16449636 USD
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13732188
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2020Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13732188
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13732188
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13649962
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13649962
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2021 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
46947 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
10496672 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
27524311 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10414809 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1615369 USD
CY2021Q3 us-gaap Short Term Investments
ShortTermInvestments
10373831 USD
CY2020Q3 us-gaap Short Term Investments
ShortTermInvestments
10582527 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
19437879 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
14408538 USD
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
953945 USD
CY2020Q3 us-gaap Other Assets Current
OtherAssetsCurrent
585436 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
71506247 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
52522809 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4997658 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4952819 USD
CY2021Q3 us-gaap Long Term Investments
LongTermInvestments
36912777 USD
CY2020Q3 us-gaap Long Term Investments
LongTermInvestments
25143000 USD
CY2021Q3 us-gaap Goodwill
Goodwill
4708511 USD
CY2020Q3 us-gaap Goodwill
Goodwill
4708511 USD
CY2021Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4696151 USD
CY2020Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4986216 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2305413 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2539100 USD
CY2021Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
365467 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
178118 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
418976 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
266857 USD
CY2021Q3 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
49407295 USD
CY2020Q3 clfd Assets Noncurrent Excluding Property Plant And Equipment
AssetsNoncurrentExcludingPropertyPlantAndEquipment
37821802 USD
CY2021Q3 us-gaap Assets
Assets
125911200 USD
CY2020Q3 us-gaap Assets
Assets
95297430 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
914565 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
665584 USD
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
9214782 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3689587 USD
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
8729293 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
4856885 USD
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1612833 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1202753 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
20471473 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2129343 USD
CY2021Q3 us-gaap Liabilities
Liabilities
22086842 USD
CY2020Q3 us-gaap Liabilities
Liabilities
12544152 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
137322 USD
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
136500 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
58245783 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
57502905 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
45441253 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
25113873 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
103824358 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
82753278 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
125911200 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
95297430 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140755399 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93074514 USD
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
79577506 USD
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
55160316 USD
CY2021 us-gaap Gross Profit
GrossProfit
61177893 USD
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
29530198 USD
CY2020 us-gaap Gross Profit
GrossProfit
37914198 USD
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
35943752 USD
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9776377 USD
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3151566 USD
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2301803 USD
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2421754 USD
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
209612 USD
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
7326 USD
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
10902839 USD
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
6655773 USD
CY2021 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2046004 USD
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
25234141 USD
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
8384000 USD
CY2021 us-gaap Investment Income Interest
InvestmentIncomeInterest
500120 USD
CY2020 us-gaap Investment Income Interest
InvestmentIncomeInterest
770950 USD
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
25734261 USD
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9154950 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5406881 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1861884 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
20327380 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
7293066 USD
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.48
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.47
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13720699
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13643355
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13784293
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13643355
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
74933387 USD
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
773555 USD
CY2020 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
428654 USD
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2020 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
348776 USD
CY2020 clfd Stock Issued During Period Value Stock Options Exercised Net Of Shares Exchanged For Payment
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesExchangedForPayment
9564 USD
CY2020 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
176416 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
7293066 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
82753278 USD
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1280135 USD
CY2021 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 USD
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
383697 USD
CY2021 clfd Stock Issued During Period Value Stock Options Exercised Net Of Shares Exchanged For Payment
StockIssuedDuringPeriodValueStockOptionsExercisedNetOfSharesExchangedForPayment
-458017 USD
CY2021 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
462115 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
20327380 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
103824358 USD
CY2021 us-gaap Net Income Loss
NetIncomeLoss
20327380 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
7293066 USD
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
64327 USD
CY2021 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-187349 USD
CY2020 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-279808 USD
CY2021 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-0 USD
CY2020 us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-5785 USD
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
1280135 USD
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
773555 USD
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9150819 USD
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1378033 USD
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
13115773 USD
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
5395558 USD
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
531201 USD
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-127773 USD
CY2020 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
1806198 USD
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
24808755 USD
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
34056930 USD
CY2021 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
13255000 USD
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-536435 USD
CY2020 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
35822000 USD
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41128 USD
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13599759 USD
CY2021Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
47286608 USD
CY2020Q3 us-gaap Held To Maturity Securities
HeldToMaturitySecurities
35725527 USD
CY2021Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
10373831 USD
CY2020Q3 us-gaap Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount
10582527 USD
CY2021Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
36912777 USD
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 USD
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
428654 USD
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
383697 USD
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
348776 USD
CY2021 clfd Payments For Proceeds From Tax Withholding Stock Options Exercised
PaymentsForProceedsFromTaxWithholdingStockOptionsExercised
458017 USD
CY2020 clfd Payments For Proceeds From Tax Withholding Stock Options Exercised
PaymentsForProceedsFromTaxWithholdingStockOptionsExercised
-9564 USD
CY2021 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
462115 USD
CY2020 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
176416 USD
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-246730 USD
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3233355 USD
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6367915 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16449636 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
10081721 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13216281 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16449636 USD
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5504985 USD
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1442079 USD
CY2021 clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
1271472 USD
CY2020 clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
97811 USD
CY2020Q3 us-gaap Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount
HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount
25143000 USD
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 USD
CY2020 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
-0 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
289085 USD
CY2021Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
2481890 USD
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1033021 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
289085 USD
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
-209612 USD
CY2021 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
-0 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
79473 USD
CY2019Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
289085 USD
CY2021Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
23071833 USD
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
12287134 USD
CY2021Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3361576 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
2048514 USD
CY2021Q3 us-gaap Inventory Gross
InventoryGross
28915299 USD
CY2020Q3 us-gaap Inventory Gross
InventoryGross
15368669 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
1390988 USD
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
960131 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
27524311 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
14408538 USD
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
15066343 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
13491460 USD
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10068685 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
8538641 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4997658 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4952819 USD
CY2021 us-gaap Depreciation
Depreciation
1699311 USD
CY2020 us-gaap Depreciation
Depreciation
1944186 USD
CY2021 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 pure
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 USD
CY2021Q3 clfd Number Of Patents Granted
NumberOfPatentsGranted
30 pure
CY2021Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8154145 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3457994 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4696151 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7789539 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2803323 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4986216 USD
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
602492 USD
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
477568 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
592192 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
531237 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
497387 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
453342 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
325920 USD
CY2021Q3 clfd Finitelived Intangible Asset Expected Amortization Total
FinitelivedIntangibleAssetExpectedAmortizationTotal
2400078 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P4Y8M15D
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.43
CY2021 us-gaap Net Income Loss
NetIncomeLoss
20327380 USD
CY2020 us-gaap Net Income Loss
NetIncomeLoss
7293066 USD
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13720699
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13643355
CY2021 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
63594
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1243499 USD
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1269542 USD
CY2021 us-gaap Advertising Expense
AdvertisingExpense
436253 USD
CY2020 us-gaap Advertising Expense
AdvertisingExpense
296571 USD
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y8M15D
CY2020 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13784293
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13643355
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.48
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.53
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.47
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.53
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
337100
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"/> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;"><b>Use of Estimates: </b>The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, related revenues and expenses and disclosure about contingent assets and liabilities at the date of the financial statements.  Significant estimates include the rebates related to revenue recognition, stock-based compensation and the valuation of inventory, long-lived assets, finite lived intangible assets and goodwill.  Actual results <em style="font: inherit;"> may </em>differ materially from these estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 8pt;">For the purposes of comparability, certain prior period amounts have been reclassified to conform to current period classification. There was <em style="font: inherit;">no</em> impact to prior period net income or shareholders’ equity.</p>
CY2014Q4 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
8000000 USD
CY2017Q2 clfd Stock Repurchase Program Increase In Authorized Amount
StockRepurchaseProgramIncreaseInAuthorizedAmount
4000000 USD
CY2017Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
12000000 USD
CY2021Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
4980671 USD
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
667465
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2529274 USD
CY2021 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1280135 USD
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
773555 USD
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
105089
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
23.74
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
121350
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.469 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0024 pure
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
79833
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
44000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
1314900 USD
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
332468 USD
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
290750
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
11.86
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
121350
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
12.43
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
4.62
CY2020 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
26750
CY2020 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
4.01
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
48250
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.35
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
337100
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.48
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
105089
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
23.74
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
8.14
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
101966
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
12.47
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
38709
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
13.68
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
301514
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.25
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
51201
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y3M14D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.28
CY2021Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1631575 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
97333
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P2Y2M8D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
12.76
CY2020Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
720826 USD
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
301514
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y2M19D
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.25
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8411728 USD
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
337100
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y5M4D
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
12.48
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
720831 USD
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
11754
CY2021 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
39.32
CY2020 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
10038
CY2020 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
17.57
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
5154287 USD
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
1966491 USD
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
439944 USD
CY2020 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
175201 USD
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
5594231 USD
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
2141692 USD
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-234297 USD
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-252929 USD
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-187350 USD
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-279808 USD
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5406881 USD
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1861884 USD
CY2021Q3 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
518526 USD
CY2020Q3 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
386296 USD
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.022 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.020 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.005 pure
CY2021 clfd Effective Income Tax Rate Reconciliation Expiration Of State Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationExpirationOfStateNetOperatingLossPercent
-0 pure
CY2020 clfd Effective Income Tax Rate Reconciliation Expiration Of State Net Operating Loss Percent
EffectiveIncomeTaxRateReconciliationExpirationOfStateNetOperatingLossPercent
-0.004 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.007 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.025 pure
CY2021 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.015 pure
CY2020 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.001 pure
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.210 pure
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.203 pure
CY2021Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
933000 USD
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
845000 USD
CY2021Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
91924 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
86319 USD
CY2021Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
379572 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
419896 USD
CY2021Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
300032 USD
CY2020Q3 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
351446 USD
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
230553 USD
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
169730 USD
CY2021Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
48505 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
43233 USD
CY2021Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
519408 USD
CY2020Q3 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
467010 USD
CY2021Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
683051 USD
CY2020Q3 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill
646916 USD
CY2021Q3 clfd Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
365467 USD
CY2020Q3 clfd Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
178118 USD
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2021Q3 clfd Deferred Tax Assets Liabilities Net Of Valuation Allowance
DeferredTaxAssetsLiabilitiesNetOfValuationAllowance
365467 USD
CY2020Q3 clfd Deferred Tax Assets Liabilities Net Of Valuation Allowance
DeferredTaxAssetsLiabilitiesNetOfValuationAllowance
178118 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2021 clfd Deferred Tax Asset Valuation Allowance Income Tax Benefit Adjustment
DeferredTaxAssetValuationAllowanceIncomeTaxBenefitAdjustment
0 USD
CY2021 clfd Deferred Tax Asset Valuation Allowance State Nol Expiration Reversal
DeferredTaxAssetValuationAllowanceStateNolExpirationReversal
0 USD
CY2021Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2019Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
47014 USD
CY2020 clfd Deferred Tax Asset Valuation Allowance Income Tax Benefit Adjustment
DeferredTaxAssetValuationAllowanceIncomeTaxBenefitAdjustment
-5235 USD
CY2020 clfd Deferred Tax Asset Valuation Allowance State Nol Expiration Reversal
DeferredTaxAssetValuationAllowanceStateNolExpirationReversal
-41779 USD
CY2020Q3 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 USD
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140755399 USD
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
93074514 USD
CY2021 clfd Revenues Percent
RevenuesPercent
1 pure
CY2020 clfd Revenues Percent
RevenuesPercent
1 pure
CY2021 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
914942 USD
CY2020 us-gaap Defined Contribution Plan Employer Discretionary Contribution Amount
DefinedContributionPlanEmployerDiscretionaryContributionAmount
838946 USD
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
1216460 USD
CY2020 us-gaap Operating Lease Expense
OperatingLeaseExpense
1126145 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
217552 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
0 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
986844 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
943682 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
516725 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
0 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2664803 USD
CY2021Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
134869 USD
CY2021Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
2529934 USD
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y1M2D
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0341 pure
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y11M26D
CY2020Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0348 pure
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
1289982 USD
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
812107 USD

Files In Submission

Name View Source Status
0001171843-21-007797-index-headers.html Edgar Link pending
clfd-20210930_pre.xml Edgar Link unprocessable
0001171843-21-007797-index.html Edgar Link pending
0001171843-21-007797.txt Edgar Link pending
0001171843-21-007797-xbrl.zip Edgar Link pending
clfd-20210930.xsd Edgar Link pending
clfd-20210930_cal.xml Edgar Link unprocessable
clfd-20210930_def.xml Edgar Link unprocessable
clfd-20210930_lab.xml Edgar Link unprocessable
clfd20210930_10k.htm Edgar Link pending
clfd20210930_10k_htm.xml Edgar Link completed
ex_303107.htm Edgar Link pending
ex_303108.htm Edgar Link pending
ex_303109.htm Edgar Link pending
ex_303110.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending